Tumor Recurrence of Breast Cancer Associated with Pulmonary Thromboembolism and Septic Shock: Case Report
Asian Journal of Case Reports in Medicine and Health, Volume 5, Issue 1,
Page 209-214
Abstract
Aims: Breast cancer is a malignant neoplasm caused by disordered clonal proliferation of breast cells, resulting from the influence of hormonal exposure or inherited susceptible genes.
Case Presentation: The present report is about a female patient with comorbidities, such as systemic arterial hypertension and depression, and with a previous history of breast cancer in 2008 and 2009 and underwent a mastectomy in 2015. She was admitted for investigation of tumor recurrence, and was diagnosed with a primary breast tumor, estrogen and progesterone receptor, which gave rise to a series of complications, culminating in septic shock and fatal outcome.
Discussion: According to the Global Cancer Observatory, breast cancer is the most common malignant neoplasm in the world.
Conclusion: The importance of cancer patients, especially those with breast tumors, is emphasized to maintain follow-up after undergoing surgical treatment for removal of the tumor and subsequent remission of the disease, since the early intervention of any complication is related to greater survival and better quality of life.
- Breast neoplasms
- recurrence
- neoplasm metastasis
- septic shock
How to Cite
References
Kumar V, Abbas AK, Aster JC. Robbins & cotran pathology - Pathological basis of diseases - 9 to edit - Elsevier. 2016;9.
José Alencar Gomes da Silva National Cancer Institute. Estimate incidence of cancer in Brazil / José Alencar Gomes da Silva National Cancer Institute. – Rio de Janeiro: INCA, 2019. Brazil; 2020.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Cecilio AP, Takakura ET, Jumes JJ, Dos Santos JW, Herrera AC, Victorino VJ, et al. Breast cancer in Brazil: Epidemiology and treatment challenges. Breast Cancer Dove Med Press. 2015;7:43–9.
Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005; 93(9):1046–52.
Allred DC. Ductal carcinoma in situ: Terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010; 2010(41):134–8.
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403–10.
Jales RML, Pereira LD. Invasive lobular carcinoma of the breast - features of mammography, ultrasound and magnetic resonance imaging. Unicamp [Internet].
Available:https://drpixel.fcm.unicamp.br/conteudo/carcinoma-lobular-invasivo-damama-caracteristicas-da-mamografia-da-ultrassonografia-e-daressonancia-magnetica. Access on: 08 Aug 2021.
The American cancer society. Treatment of Breast Cancer by Stage [Internet].
Available:https://www.cancer.org/cancer/breastcancer/treatment/treatment-of-breast-cancer-by-stage.html
(Accessed on: 08 Aug 2021).
Brum IV, Guerra MR, Cintra JRD, Bustamante-Teixeira MT. Metastatic breast cancer: Clinicopathological features and survival according to the site of metastasis. Med Ribeirão Preto. 2017;50(3):158–68.
Zamboni M. Carcinoma Lymphangitis. Lung RJ. 2009;4:S54-S58
Oliveira VM de, Aoki T, Aldrighi JM. Thromboembolism and breast cancer: when to indicate drug prophylaxis? Rev Assoc Médica Bras. 2008;54:6–6.
Ministry of health (BR). National Cancer Institute. Control of Breast Cancer. Rio de Janeiro: INCA. Brazil; 2021.
Available:https://www.inca.gov.br/controle-do-cancer-de-mama/acoes-decontrole/ tratamento.
(Access on: 08 Aug 2021).
Ravetti C, Moura A, Teixeira A, Pedroso E. Sepsis in cancer patients admitted in the ICU: Epidemiology, pathophysiology, and biomarkers. Rev Med Minas Gerais; 2014.
Available:http://www.dx.doi.org/10.5935/2238-3182.20140108.
(Access on: 04 Nov 2022).
Camou F, Didier M, Leguay T, et al. Long-term prognosis of septic shock in cancer patients. Support Care Cancer 28. 2020; 1325–1333.
Available:https://doi.org/10.1007/s00520-019-04937-4
Nathan N, Sculier JP, Ameye L, Paesmans M, Bogdan-Dragos G, Meert AP. Definições de sepse e choque séptico em pacientes com câncer internados em UTI. Revista de Medicina Intensiva. 2021; 36(3):255-261.
DOI: 10.1177/0885066619894933
Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432-40. PMID: 16778259.
DOI: 10.1378/chest.129.6.1432
Ma CX, Sparano JA. Treatment approach to receptor-positive metastatic hormone, HER2-negative breast cancer: Endocrine therapy and targeted agents. Up To Date. 2020.
(Access on: 08 Aug 2021).
-
Abstract View: 365 times
PDF Download: 2 times
